A larger number of apocrine carcinomas need therefore to be studied in order to definitively assess the usefulness of TRPS1 in the differential diagnosis between primary and metastatic adenocarcinomas of the skin. This evidence concerns the gene TRPS1 and apocrine adenocarcinoma.